Brazil GMP Quality System Compliance

ANVISA B-GMP Regulatory Framework

Compliance with Brazil Good Manufacturing Practices (B-GMP) is a mandatory requirement for any medical device or In Vitro Diagnostic (IVD) manufacturer looking to access the Brazilian market. Overseen by the National Health Surveillance Agency (ANVISA), the B-GMP standards are primarily codified in RDC 665/2022. While this regulation shares many core principles with international standards like ISO 13485, it contains specific Brazilian deviations and administrative requirements that manufacturers must address to secure market authorization.

For manufacturers of Class III and IV devices, obtaining a formal B-GMP certificate from ANVISA is a prerequisite for product registration. This certification is the result of a rigorous evaluation process that ensures the manufacturer's Quality Management System (QMS) can consistently produce devices that meet safety and efficacy requirements. Failure to align your QMS with these local mandates can result in significant delays in registration or the rejection of market access applications.

Key Elements of RDC 665/2022 Compliance

Achieving B-GMP compliance requires a deep understanding of the technical nuances within the Brazilian regulation. Manufacturers must ensure their quality manuals and standard operating procedures (SOPs) explicitly address the unique expectations of ANVISA auditors.

Quality management and management responsibility

ANVISA places a heavy emphasis on management commitment to the quality system. This includes ensuring that adequate resources are allocated for quality activities and that a clear organizational structure is defined. The quality policy and objectives must be effectively communicated and implemented at all levels of the manufacturing facility.

Design controls and risk management

The design and development process must be meticulously documented, showing a clear link between user needs and technical specifications. Risk management is a central pillar of B-GMP; manufacturers must demonstrate that they have identified potential hazards and implemented effective mitigation strategies throughout the entire product lifecycle, as mandated by the latest regulatory standards.

Production and process controls

B-GMP requires robust controls over manufacturing environments and processes. This includes sterilization validation, cleanroom monitoring, and equipment maintenance protocols. Documentation must provide full traceability, allowing for the identification of raw materials, components, and personnel involved in the production of each batch or lot.

Strategic Pathways for B-GMP Certification

The route to obtaining B-GMP certification has become more diversified in recent years. Manufacturers can leverage international programs to streamline the process and reduce the frequency of physical on-site inspections by ANVISA officials.

The Medical Device Single Audit Program (MDSAP) is the most significant strategic tool available to global manufacturers. Under current ANVISA regulations, such as RDC 850/2024, audit reports generated by MDSAP-accredited auditing organizations can be used to satisfy B-GMP requirements. This allows for an accelerated certification timeline, as ANVISA may issue the B-GMP certificate based on the MDSAP report without conducting its own inspection. However, even within the MDSAP framework, manufacturers must ensure their QMS documentation remains fully compliant with the specific requirements of RDC 665/2022.

Proregulations' B-GMP Compliance Services

Our standardized service process facilitates the efficient navigation of B-GMP requirements to ensure your manufacturing site meets ANVISA's high expectations. We offer a comprehensive suite of solutions to manage every stage of the quality system compliance lifecycle:

• B-gmp gap analysis and QMS auditing
  We conduct a thorough assessment of your existing quality management system against RDC 665/2022 to identify and remediate compliance gaps.
• Quality system documentation development
  Our experts assist in drafting and refining SOPs, quality manuals, and technical files to meet the specific linguistic and technical requirements of Brazil.
• MDSAP transition and support
  We provide strategic guidance on utilizing the MDSAP pathway to secure B-GMP certification, helping you optimize your audit reports for ANVISA recognition.
• Mock ANVISA audit and staff training
  We perform simulated audits to prepare your team for the rigors of a physical ANVISA inspection, focusing on common audit findings and response strategies.
• Post-market surveillance and vigilance
  We help establish compliant systems for complaint handling, adverse event reporting, and field safety corrective actions as required by Brazilian law.
• Certification maintenance and renewals
  We monitor regulatory changes and assist with the periodic renewal of your B-GMP certificate to ensure uninterrupted market access.

If you are interested in our Brazil GMP quality system compliance services and wish to accelerate your market entry in Brazil, please feel free to contact us.